Results
Zydus Lifesciences Q2 FY27 Investor Call Recording
Zydus Lifesciences disclosed availability of Q2/H1 FY27 investor call audio recording on its website.
The disclosure was made pursuant to SEBI Listing Regulations 30 and 46(2)(oa) compliance requireme
